Open Access

[Corrigendum] Silencing of RIPK4 inhibits epithelial‑mesenchymal transition by inactivating the Wnt/β‑catenin signaling pathway in osteosarcoma

  • Authors:
    • Zhigang Yi
    • Yanchuan Pu
    • Ruoyan Gou
    • Yonggang Chen
    • Xiaojun Ren
    • Wenzhong Liu
    • Ping Dong
  • View Affiliations

  • Published online on: January 4, 2022     https://doi.org/10.3892/mmr.2022.12585
  • Article Number: 69
  • Copyright : © Yi et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Subsequently to the publication of the above article, the authors have realized that the same western blotting data shown for the vimentin bands for the U2OS cell line in Fig. 3B on p. 1159 had inadvertently been re‑used for the β‑catenin bands for the U2OS cell line in Fig. 5A on p. 1161. The authors have re‑examined their original data, and have realized that Fig. 5 was assembled incorrectly. The corrected version of Fig. 5, showing the correct β‑catenin bands for the U2OS cell line, is shown opposite. Note that this error did not quantitatively affect either the results or the overall conclusions reported in this paper. The authors are grateful to the Editor of Molecular Medicine Reports for allowing them this opportunity to publish a Corrigendum, and they apologize to the readership for any inconvenience caused. [the original article was published in Molecular Medicine Reports 21: 1154‑1162, 2020; DOI: 10.3892/mmr.2020.10939]

Related Articles

Journal Cover

February-2022
Volume 25 Issue 2

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Yi Z, Pu Y, Gou R, Chen Y, Ren X, Liu W and Dong P: [Corrigendum] Silencing of RIPK4 inhibits epithelial‑mesenchymal transition by inactivating the Wnt/β‑catenin signaling pathway in osteosarcoma. Mol Med Rep 25: 69, 2022
APA
Yi, Z., Pu, Y., Gou, R., Chen, Y., Ren, X., Liu, W., & Dong, P. (2022). [Corrigendum] Silencing of RIPK4 inhibits epithelial‑mesenchymal transition by inactivating the Wnt/β‑catenin signaling pathway in osteosarcoma. Molecular Medicine Reports, 25, 69. https://doi.org/10.3892/mmr.2022.12585
MLA
Yi, Z., Pu, Y., Gou, R., Chen, Y., Ren, X., Liu, W., Dong, P."[Corrigendum] Silencing of RIPK4 inhibits epithelial‑mesenchymal transition by inactivating the Wnt/β‑catenin signaling pathway in osteosarcoma". Molecular Medicine Reports 25.2 (2022): 69.
Chicago
Yi, Z., Pu, Y., Gou, R., Chen, Y., Ren, X., Liu, W., Dong, P."[Corrigendum] Silencing of RIPK4 inhibits epithelial‑mesenchymal transition by inactivating the Wnt/β‑catenin signaling pathway in osteosarcoma". Molecular Medicine Reports 25, no. 2 (2022): 69. https://doi.org/10.3892/mmr.2022.12585